Two Brazilian doctors have been sent to prison for selling contraband organs to the US as part of a suspected trafficking scheme, Brazilian law enforcement officials said on Friday.
The two men, Celso Roberto Scafi and Claudio Rogerio Carneiro Fernandes, are both urologists who practiced medicine in the state of Minas Gerais.
However, Brazilian officials allege they also were part of an organ-trafficking “mafia” in which kidneys, livers and other organs and body tissues were illegally removed from patients, some of whom were still alive, and sold.
The men were convicted at a trial in February last year, but appealed to a Brazilian higher court, which on Thursday upheld the lower court’s verdict.
The men were remanded into custody and are being held at a prison in Pocos de Caldas, 500km from state capital Belo Horizonte.
A Brazilian judge in the case last week sentenced the men to prison terms of 17 and 18 years, according to Brazilian news reports. Their licenses to practice medicine also have been revoked. Brazilian authorities said a search was underway for a third physician in the scheme, anesthesiologist Sergio Poli Gaspar, who failed to turn himself in to authorities and is considered a fugitive from justice.
The case dealt with a 10-year old boy, Paulo Veronesi Pavesi, whose organs were removed without permission and sent to the US after his accidental death in a fall.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS